Skip to content

CB MEDIC: what changed

BE 0779.327.494Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€84,720
2024 · €96,887-€12,167
Equity
€150,012
2024 · €150,012
Cash
€165,145
2024 · €159,252+€5,894
Balance sheet total
€245,933
2024 · €233,759+€12,174

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€20,221

    up €20,221 (+37.9%), from €53,402 to €73,623

  • Deferred charges and accrued income -€12,241

    down €12,241 (-79.6%), from €15,369 to €3,128

  • Cash +€5,894

    up €5,894 (+3.7%), from €159,252 to €165,145

    mainly Net result for the year (+€84,720) and Other debts (+€13,921)

Equity and liabilities
  • Other debts +€13,921

    up €13,921 (+17.0%), from €82,000 to €95,921

Income statement
  • Gross operating margin -€17,084

    down €17,084 (-13.1%), from €130,043 to €112,960

  • Taxes -€6,449

    down €6,449 (-22.1%), from €29,146 to €22,696

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €96,887
Gross operating margin -€17,084
Depreciation -€981
Financial income -€611
Financial charges +€59
Taxes +€6,449
Result 2025 €84,720
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€93,844
Investment -€3,230
Financing -€84,720
Cash 2024 €159,252
Net result for the year +€84,720
Depreciation +€4,930
Receivables within one year -€20,221
Deferred charges and accrued income +€12,241
Trade debts -€259
Tax, wage and social debts -€1,489
Other debts +€13,921
Investment in fixed assets (net) -€3,230
Contributions, distributions and other -€84,720
Cash 2025 €165,145
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €233,759 €245,933 +€12,174 +5.2%
Fixed assets 21/28 €5,736 €4,036 -€1,700 -29.6%
Tangible fixed assets 22/27 €5,736 €4,036 -€1,700 -29.6%
Plant, machinery and equipment 23 - €2,860 +€2,860
Furniture and vehicles 24 €5,736 €1,176 -€4,560 -79.5%
Current assets 29/58 €228,023 €241,897 +€13,874 +6.1%
Amounts receivable within one year 40/41 €53,402 €73,623 +€20,221 +37.9%
Other amounts receivable 41 €53,402 €73,623 +€20,221 +37.9%
Cash at bank and in hand 54/58 €159,252 €165,145 +€5,894 +3.7%
Deferred charges and accrued income 490/1 €15,369 €3,128 -€12,241 -79.6%
Total equity and liabilities 10/49 €233,759 €245,933 +€12,174 +5.2%
Equity 10/15 €150,012 €150,012 = 0.0%
Contributions 10/11 €1 €1 = 0.0%
Reserves 13 €150,011 €150,011 = 0.0%
Distributable reserves 133 €150,011 €150,011 = 0.0%
Amounts payable 17/49 €83,747 €95,921 +€12,174 +14.5%
Amounts payable within one year 42/48 €83,747 €95,921 +€12,174 +14.5%
Trade debts 44 €259 - -€259
Suppliers 440/4 €259 - -€259
Taxes, remuneration and social security 45 €1,489 - -€1,489
Taxes 450/3 €1,489 - -€1,489
Other amounts payable 47/48 €82,000 €95,921 +€13,921 +17.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,949 €4,930 +€981 +24.8%
Gross operating margin 9900 €130,043 €112,960 -€17,084 -13.1%
Operating profit (loss) 9901 €126,094 €108,030 -€18,064 -14.3%
Financial income 75/76B €724 €113 -€611 -84.4%
Recurring financial income 75 €724 €113 -€611 -84.4%
Financial charges 65/66B €785 €726 -€59 -7.5%
Recurring financial charges 65 €785 €726 -€59 -7.5%
Profit (loss) for the period before taxes 9903 €126,033 €107,416 -€18,616 -14.8%
Income taxes 67/77 €29,146 €22,696 -€6,449 -22.1%
Profit (loss) for the period 9904 €96,887 €84,720 -€12,167 -12.6%
Profit (loss) for the period to be appropriated 9905 €96,887 €84,720 -€12,167 -12.6%

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€337,484 to €442,476

Midpoint €381,231 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €150,012
Capitalised earnings €524,957 to €734,940
Indication €337,484 to €442,476

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€150,012
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€150,012

Capitalised earnings

net result for the year (9904)
2025
€84,720
2024
€96,887
2023
€38,875
2022
€96,249
excluding non-recurring income and charges
€96,275
Average result
€73,494
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€524,957 / €612,450 / €734,940

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.